Effect of adenosine triphosphate on ribociclib-induced skin toxicity in rats.

IF 1.6 4区 医学 Q3 OPHTHALMOLOGY
Nergis Akbaş, Emin Murat Akbaş, Zeynep Süleyman, Betül Çiçek, Ahmet Gökhan Ağgül, Behzad Mokhtare, Halis Süleyman
{"title":"Effect of adenosine triphosphate on ribociclib-induced skin toxicity in rats.","authors":"Nergis Akbaş,&nbsp;Emin Murat Akbaş,&nbsp;Zeynep Süleyman,&nbsp;Betül Çiçek,&nbsp;Ahmet Gökhan Ağgül,&nbsp;Behzad Mokhtare,&nbsp;Halis Süleyman","doi":"10.1080/15569527.2023.2166524","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Ribociclib is a CDK4/6 inhibitor approved for the treatment of breast cancer; it inhibits the activity of CDK4/6 by competitively binding to adenosine 5'-triphosphate (ATP) binding sites. Although generally well-tolerated, ribociclib has been connected to a number of serious dermatologic complications. This study explored the effects of ATP on ribociclib-induced skin damage.</p><p><strong>Materials and methods: </strong>Using a rat model, ATP 25 mg/kg was injected intraperitoneally in the ATP + Ribociclib (ATR) group (<i>n</i> = 6). Distilled water as solvent was applied to the healthy control (HC) group (<i>n</i> = 6) and ribociclib (RCB) group (<i>n</i> = 6). One hour after ATP and solvent administration, ribociclib (200 mg/kg) suspension prepared in distilled water was administered to the stomach by gavage (ATR and RCB groups). This was repeated once a day for 15 d. After that period, biochemical markers were studied in the skin tissues and histopathological evaluations were conducted.</p><p><strong>Results: </strong>In the histopathological evaluation of the RCB group, dermal necrosis, degeneration in hair follicles, and pycnosis in keratinocytes were observed. Only mild degeneration was observed in the ATR group; the HC group had a normal histological appearance. The malondialdehyde (MDA) values were significantly higher and the superoxide dismutase (SOD), catalase (CAT), and total glutathione (tGSH) levels were significantly lower in the RCB group in comparison to the HC group (<i>p</i> < .001). ATP reduced the ribociclib-induced increases in the MDA values and decreased the SOD, CAT, and tGSH levels in the ATR group (<i>p</i> < .001).</p><p><strong>Conclusion: </strong>ATP may be useful in the treatment of ribociclib-induced skin damage.</p>","PeriodicalId":11023,"journal":{"name":"Cutaneous and Ocular Toxicology","volume":"42 1","pages":"32-37"},"PeriodicalIF":1.6000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cutaneous and Ocular Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15569527.2023.2166524","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Purpose: Ribociclib is a CDK4/6 inhibitor approved for the treatment of breast cancer; it inhibits the activity of CDK4/6 by competitively binding to adenosine 5'-triphosphate (ATP) binding sites. Although generally well-tolerated, ribociclib has been connected to a number of serious dermatologic complications. This study explored the effects of ATP on ribociclib-induced skin damage.

Materials and methods: Using a rat model, ATP 25 mg/kg was injected intraperitoneally in the ATP + Ribociclib (ATR) group (n = 6). Distilled water as solvent was applied to the healthy control (HC) group (n = 6) and ribociclib (RCB) group (n = 6). One hour after ATP and solvent administration, ribociclib (200 mg/kg) suspension prepared in distilled water was administered to the stomach by gavage (ATR and RCB groups). This was repeated once a day for 15 d. After that period, biochemical markers were studied in the skin tissues and histopathological evaluations were conducted.

Results: In the histopathological evaluation of the RCB group, dermal necrosis, degeneration in hair follicles, and pycnosis in keratinocytes were observed. Only mild degeneration was observed in the ATR group; the HC group had a normal histological appearance. The malondialdehyde (MDA) values were significantly higher and the superoxide dismutase (SOD), catalase (CAT), and total glutathione (tGSH) levels were significantly lower in the RCB group in comparison to the HC group (p < .001). ATP reduced the ribociclib-induced increases in the MDA values and decreased the SOD, CAT, and tGSH levels in the ATR group (p < .001).

Conclusion: ATP may be useful in the treatment of ribociclib-induced skin damage.

三磷酸腺苷对核环苷所致大鼠皮肤毒性的影响。
目的:Ribociclib是一种被批准用于治疗乳腺癌的CDK4/6抑制剂;它通过竞争性结合腺苷5'-三磷酸(ATP)结合位点来抑制CDK4/6的活性。虽然一般耐受性良好,但核糖环尼与许多严重的皮肤并发症有关。本研究探讨了ATP在核环苷诱导的皮肤损伤中的作用。材料与方法:采用大鼠模型,ATP + Ribociclib (ATR)组(n = 6)腹腔注射ATP 25 mg/kg。健康对照(HC)组(n = 6)和核糖环苷(RCB)组(n = 6)采用蒸馏水作为溶剂。ATP和溶剂给药1小时后,用蒸馏水配制的核糖素(200 mg/kg)混悬液灌胃(ATR组和RCB组)。每天重复一次,持续15 d。在此之后,研究皮肤组织中的生化标志物并进行组织病理学评价。结果:RCB组的组织病理学观察结果为真皮坏死、毛囊变性、角化细胞增生。ATR组仅轻度退变;HC组组织学外观正常。与HC组相比,RCB组丙二醛(MDA)值显著升高,超氧化物歧化酶(SOD)、过氧化氢酶(CAT)和总谷胱甘肽(tGSH)水平显著降低(p)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.30
自引率
6.20%
发文量
40
审稿时长
1 months
期刊介绍: Cutaneous and Ocular Toxicology is an international, peer-reviewed journal that covers all types of harm to cutaneous and ocular systems. Areas of particular interest include pharmaceutical and medical products; consumer, personal care, and household products; and issues in environmental and occupational exposures. In addition to original research papers, reviews and short communications are invited, as well as concise, relevant, and critical reviews of topics of contemporary significance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信